Homatropine Hydrobromide (homatropine Hbr)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

Homatropine hydrobromide, a tertiary amine antimuscarinic, is a mydriatic and cycloplegic.

Homatropine hydrobromide is used to produce mydriasis and cycloplegia for refraction and in the management of acute inflammatory conditions of the uveal tract.

Generic name: homatropine Hbr
Pronunciation: (hoe-MAT-roe-peen)

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Homatropine Hydrobromide

Intelligence content is not available yet.

Indications

The following indications are listed for Homatropine Hydrobromide:

  • Cycloplegia
  • Perioperative Mydriasis
  • Uveitis

Also known as: Paraoperative Mydriasis, Perioperative Pupil Dilation, Preoperative And/Or Postoperative Mydriasis.

Dosing

To produce mydriasis and cycloplegia for refraction in adults, 1 or 2 drops of a 2 or 5% solution may be instilled onto the eye(s) immediately before the procedure and repeated in 5-10 minutes if necessary. In children, the usual dosage to produce mydriasis and cycloplegia for refraction is 1 drop of a 2% solution instilled onto the eye(s) immediately before the procedure and repeated at 10-minute intervals as necessary.

For pupillary dilation in the treatment of acute inflammatory conditions of the uveal tract in adults, the usual dosage is 1 or 2 drops of a 2 or 5% solution instilled onto the eye(s) 2 or 3 times daily, and if necessary, as often as every 3 or 4 hours; in children, the usual dosage is 1 drop of a 2% solution 2 or 3 times daily.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

No ICD codes are available for this drug.

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data